The markets advanced during the midday with the Dow gaining 60 points to 15,360 even as consumer sentiment fell to a five month low. Nasdaq held steady at 3715.
On the upside
Rockwell Medical (Nasdaq: RMTI) received the Barbarian at the Gate designation from Trade-Ideas for trading above its daily resistance level.
Cell Therapeutics (Nasdaq: CTIC) will raise a net of $14.8 million through the sale of preferred stock.
Credit Suisse upgraded Safeway (NYSE: SWY) from an Underperform rating to an Outperform rating.
On the downside
Prana Biotechnology (Nasdaq: PRAN) delayed reporting results for its Huntington disease Reach 2HD trial until 2014.
Profit taking weighed down shares of Avanir Pharmaceuticals (Nasdaq: AVNR).
Shares of OCI Resources (NYSE: OCIR) fell on its first trading day.
In the broad market, advancing issues outpaced decliners by a margin of more than 9 to 7 on both the NYSE and on Nasdaq. The broader S&P 500 added 3 points to 1687.
